Allena Pharmaceuticals Receives $15,000,000 Series A Round

  • Feed Type
  • Date
    11/17/2011
  • Company Name
    Allena Pharmaceuticals
  • Mailing Address
    One Newton Executive Park Newton, MA 02462
  • Company Description
    Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
  • Website
    http://www.allenapharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to accelerate the development of Allena’s non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
  • M&A Terms
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.